the aid library

LIST OPTIONS

Filter

14036

Guidelines for malaria vector control
recommended

World Health Organization WHO (2019) C_WHO

Vector control is a vital component of malaria prevention, control and elimination strategies because it can be highly effective in providing personal protection and/or reducing disease transmission.

Download (341)

View PDF (562)

RELATÓRIO MUNDIAL SOBRE A DEFICIÊNCIA - Sumário

World Health Organization (WHO) & The World Bank (WB) (2011) C_WHO

Download (2137)

View PDF (1208)

Zambia Report on the open ears to learn project implemented in Western Province

Zambia National Association of the Hearing Impaired (ZNAHI) (2010) C1

External Link

External Link (1908)

Early Warning, Alert and Response Network (EWARN)

World Health Organization WHO (2014) CC

Early warning systems for disease outbreaks are surveillance systems that collect information on a selected list of epidemic-prone diseases in order to trigger prompt public health interventions. They function in humanitarian emergency situations when the routine public health surveillance systems o... more

Download (507)

View PDF (513)

Eau, assainissement et hygiène dans les établissements de santé : mesures pratiques pour parvenir à un accès universel à des soins de qualité

World Health Organization WHO; UNICEF (2019) C_WHO

Personne ne se rend dans un établissement de soins de santé pour tomber malade. On s’y rend pour aller mieux, pour accoucher, pour se faire vacciner. Cependant, des centaines de millions de gens sont confrontés à un risque accru d’infection quand ils se font soigner dans des établissements ... more

Download (283)

View PDF (321)

Selecting digital contact tracing and quarantine tools for COVID-19 : guiding principles and considerations for a stepwise approach

World Health Organization WHO, Western Pacific Region (2020) CC

Contact tracing is a key component of the COVID-19 response, particularly as societies begin to lift non-pharmaceutical interventions. However, it is a time-consuming and resource-intensive effort that depends on a trained and motivated workforce. Emergent digital contact tracing and quarantine (‎... more

Download (357)

View PDF (499)

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection
recommended

World Health Organization WHO (2021) C_WHO

15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19. The specific objectives of the analysis were to: describe the clinical char... more

Download (353)

View PDF (589)

Manejo clínico de la COVID-19: orientaciones evolutivas, 23 de junio de 2022
recommended

World Health Organization WHO (2022) C_WHO

Update, 23 de junio de 2022

Download (268)

View PDF (420)

HIV/AIDS surveillance in Europe 2017

A. Pharris; A. Stengaard World Health Organization (Europe); European Centre for Disease Prevention and Control (2017) C_WHO

2016 data The report was coordinated by Anastasia Pharris and Annemarie Stengaard. Report review and production support were provided by Andrew J. Amato-Gauci, Mike Catchpole, Denis Coulombier, Masoud Dara, Nedret Emiroglu, Rachel Katterl, Shahin Khasiyev, Valentina Lazdina, Teymur Noori, Marc... more

Download (1023)

View PDF (1367)

HIV and AIDS (Poster)

Department of Health, Province of Kwazulu-Natal (2015)

Accessed 14 July 2015

Download (571)

View PDF (715)

Progress on drinking water, sanitation and hygiene in schools: 2000-2021 data update

World Health Organization WHO; UNICEF; et al. (2022) C_WHO

Special Focus on COVID-19 The report provides updated estimates for drinking water, sanitation and hygiene in schools including progress from 2015 to 2019. It highlights the rapid improvement needed to ensure students have access to handwashing facilities with soap and water during the COVID-19 pan... more

Download (300)

View PDF (380)

COVID-19: Guidelines for communicating about coronavirus disease 2019 - A guide for leaders

Pan American Health Organisation PAHO (2020) C_WHO

Risk communication encompasses all the basics of health communication but differs in the need for speed and reliance on trust. At times of crisis, leaders are called on to provide a quick, sensitive and trustworthy response.

Download (875)

View PDF (1892)

Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstratio

World Health Organization (2012)

Download (510)

View PDF (731)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (430)

View PDF (560)

Global clinical data platform for severe acute hepatitis of unknown aetiology in children case report form (CRF)

World Health Organization WHO (2022) C_WHO

Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting of anonymized, patient-level data of acute hepatitis of unknown aetiology.

Download (391)

View PDF (402)

Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men
recommended

World Health Organization WHO (2018) C_WHO

Download (1172)

View PDF (2632)

Caring for Newborns and Children in the Community. Facilitator Notes

World Health Organization; UNICEF (2011) C_WHO

Treat diarrhoea, confirmed malaria, and fast breathing

Download (2273)

View PDF (2158)

WHO Safe Childbirth Checklist Implementation Guide
recommended

World Health Organization WHO (2015) C_WHO

This implementation guide has been developed to help birth attendants and health-care leaders successfully launch and sustain use of the WHO Safe Childbirth Checklist. Development, use and implementation of the Checklist are described in this guide. It covers how to introduce and ensure continuous ... more

Download (1733)

View PDF (1224)

Standards for Prosthetics and Orthotics Service Provision. 2015-2017 work plan

Department of Essential Medicines and Health Products (EMP) and NVI World Health Organisation (WHO); USAID; ISPO (2015) C_WHO

Download (2476)

View PDF (2967)

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer)
recommended

World Health Organization WHO WHO (2012) C_WHO

Guidance for health workers

Guidelines for malaria vector control recommended

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection recommended

Manejo clínico de la COVID-19: orientaciones evolutivas, 23 de junio de 2022 recommended

Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men recommended

WHO Safe Childbirth Checklist Implementation Guide recommended

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer) recommended